Bio­con’s Bold In­te­gra­tion: Uni­fy­ing Biosim­i­lars and Gener­ics to Re­de­fine Glob­al Af­ford­able Ac­cess

2 days ago

Ex­ec­u­tive Brief: How to Fu­ture-Proof and Dif­fer­en­ti­ate Your Busi­ness with RWD/RWE

2 days ago

Glob­al part­ner­ing be­fore the term sheet: de-risk­ing bio­phar­ma deals from day one

Last week

This Founder Could­n't Find His Own Clin­i­cal Tri­al. Now He's En­rolling Hun­dreds of Pa­tients for Phar­ma's Biggest Names

3 weeks ago

CNS-3D Brain Organoids Pre­dict Clin­i­cal Seizure Li­a­bil­i­ty, New Study Da­ta

4 weeks ago

Pre­sent­ing Your Gene Ther­a­py Man­u­fac­tur­ing Plan to In­vestors: What They Ex­pect in 2026 and How to De­liv­er It

5 weeks ago

Health Eco­nom­ic Out­comes of the On­co­type DX Breast Re­cur­rence Test at a Pop­u­la­tion Health Lev­el

Last month

CMS is qui­et­ly piv­ot­ing to re­al-world ev­i­dence in next IRA phase

Last month

Fu­ji­film ex­pands glob­al life sci­ences foot­print through large-scale bio­man­u­fac­tur­ing in­vest­ments

Last month

5 ways to se­cure biotech fund­ing in 2026

Last month

South­ern Star Re­search ex­pands Asia foot­print through strate­gic in­vest­ment in Ex­pec­to Health Sci­ence

Last month

7 Re­al-World Ways RWE Is Trans­form­ing Health­care

Last month

The $50K-a-day prob­lem in clin­i­cal tri­al en­roll­ment

2 months ago

Lessons in Cat­e­go­ry Cre­ation: In Con­ver­sa­tion with Bob­by Aza­mi­an, CEO Tar­sus Phar­ma­ceu­ti­cals

2 months ago

iRe­gene Re­ports Dual Glob­al Firsts: First U.S. Dos­ing in Parkin­son’s Phase IIa for Nou­vNeu001, First En­roll­ment in Chi­na MSA Tri­al for Nou­vNeu004

2 months ago

Biggest SCOPE Buzz: Two Dis­rup­tors in Clin­i­cal Re­search Are Re­defin­ing En­roll­ment Speed

3 months ago

Da­ta as a su­per­pow­er: How In­te­grat­ed Da­ta De­liv­ery trans­forms clin­i­cal tri­al time­lines

3 months ago

A Psy­che­del­ic Re­nais­sance: How Defini­um Ther­a­peu­tics is Chang­ing How We Think about LSD and Treat Men­tal Health

3 months ago

In­side Gilead’s 2030 Strat­e­gy to Ad­vance 10 Trans­for­ma­tive Ther­a­pies

3 months ago

Can AI im­prove clin­i­cal drug de­vel­op­ment as much as it has pre­clin­i­cal re­search?

3 months ago

Sin­gle in­tra­tu­moral in­jec­tion of nov­el drug ex­tends sur­vival in MCF7 pri­ma­ry breast can­cer mouse mod­el

4 months ago

ROIS Re­flects on 2025 In­no­va­tion & In­vest­ment

4 months ago

How con­sor­tia are re­shap­ing rare on­col­o­gy tri­als

4 months ago

Pra­tia ac­cel­er­ates U.S. ex­pan­sion with ma­jor­i­ty in­vest­ment in P1 Tri­als, strength­en­ing its glob­al ear­ly-phase on­col­o­gy net­work

4 months ago
1234 Next page Last page
A service from the Financial Times